Advertisement
Advertisement

ATNM

ATNM logo

Actinium Pharmaceuticals, Inc

1.16
USD
Sponsored
0.00
-0.43%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

1.15

-0.01
-0.43%

ATNM Earnings Reports

Positive Surprise Ratio

ATNM beat 23 of 40 last estimates.

57%

Next Report

Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.19
Implied change from Q3 25 (Revenue/ EPS)
-100.00%
/
+18.75%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-9.52%

Actinium Pharmaceuticals, Inc earnings per share and revenue

On Nov 14, 2025, ATNM reported earnings of -0.16 USD per share (EPS) for Q3 25, beating the estimate of -0.32 USD, resulting in a 51.49% surprise. Revenue reached 90.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a +14.17% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.19 USD, with revenue projected to reach -- USD, implying an increase of 18.75% EPS, and decrease of -100.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Actinium Pharmaceuticals, Inc reported EPS of -$0.16, beating estimates by 51.49%, and revenue of $90.00K, 0% as expectations.
The stock price moved up 14.17%, changed from $1.27 before the earnings release to $1.45 the day after.
The next earning report is scheduled for Mar 30, 2026.
Based on 6 analysts, Actinium Pharmaceuticals, Inc is expected to report EPS of -$0.19 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement